By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akebia Therapeutics, Inc. 

9987 Carver Road
Suite 420
Cincinnati  Ohio  45242  U.S.A.
Phone: 513-618-0931 Fax: 513-618-0950


Company News
Akebia Therapeutics, Inc. (AKBA) Appoints Michael Clayman, M.D. And Maxine Gowen, Ph.D. To Its Board Of Directors 7/17/2014 11:37:00 AM
Akebia Therapeutics, Inc. (AKBA) Added To Russell 3000®, Russell 2000® And Russell Global Indexes 6/30/2014 11:25:22 AM
Akebia Therapeutics, Inc. (AKBA), Trading M&A For An IPO—Becoming A Huge Contender In Anemia Drug Race 6/9/2014 6:54:03 AM
Akebia Therapeutics, Inc. (AKBA) To Present At The Annual UBS Global Healthcare Conference 5/12/2014 10:04:00 AM
Akebia Therapeutics, Inc. (AKBA) Announces Completion Of Enrollment In Its Phase 2b Clinical Study Of AKB-6548 4/15/2014 8:59:54 AM
Akebia Therapeutics, Inc. (AKBA) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 3/26/2014 9:38:25 AM
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014 6:50:37 AM
Startup, Akebia Therapeutics, Inc., Files For $75 Million IPO 2/19/2014 7:44:59 AM
Akebia Therapeutics, Inc. Appoints Michael Wyzga To Its Board Of Directors 2/18/2014 8:26:58 AM
Akebia Therapeutics, Inc. Strengthens Its Leadership Team With Key Additions 1/13/2014 7:27:03 AM